GF CSI Medical Service ETF (560260) Rises 1.46% Intraday, Institutions Expect Promising Prospects for Private Healthcare Amid Rising Demand

NewTimeSpace News: As of 14:38 on January 29, 2026, the CSI Medical Index (399989) surged strongly by 1.49%. Component stocks performed impressively: Tongce Medical rose 4.60%, Weining Health climbed 4.22%, Aimeike (Amicco) advanced 3.84%, and other stocks including Yirui Technology and Tigermed also followed the upward trend. TheGF CSI Medical Service ETF (560260) rose 1.46% to close at RMB 0.91 intraday. Over a longer horizon, as of January 28, 2026, the ETF has achieved a cumulative increase of 2.53% in the past month. (The stocks listed above are only index components and do not constitute specific investment recommendations.)

In terms of liquidity, theGF CSI Medical Service ETF recorded an intraday turnover rate of 0.54% and a trading volume of RMB 8.4606 million. Looking back, as of January 28, its average daily trading volume in the past month reached RMB 16.1245 million.

In terms of scale, the ETF's latest size stood at RMB 1.548 billion. (Data source: Wind)

Regarding capital inflows, the latest capital inflows and outflows of theGF CSI Medical Service ETF were balanced. Over the past 5 trading days, it has achieved net capital inflows on 3 days, with a total accumulated capital inflow of RMB 20.9701 million and an average daily net inflow of RMB 4.1940 million. (Data source: Wind)

As of January 28, the ETF's net value has risen 3.21% in the past two years. In terms of profitability, as of January 28, 2026, since its establishment, theGF CSI Medical Service ETF has achieved a maximum monthly return of 29.94%, the longest consecutive upward period of 5 months with a cumulative increase of 24.01%, and an average return of 6.96% in rising months. As of January 28, 2026, the ETF's annualized excess return over the benchmark since its establishment was 1.58%.

In terms of drawdown, as of January 28, 2026, the ETF's maximum drawdown since the beginning of this year was 8.77%, with a relative benchmark drawdown of 0.04%, indicating a low drawdown risk among comparable funds.

In terms of fees, the ETF has a management fee rate of 0.50% and a custodian fee rate of 0.05%, which are at a relatively low level among comparable funds.

In terms of tracking accuracy, as of January 28, 2026, the ETF's tracking error in the past two months was 0.013%, ranking the highest in tracking accuracy among comparable funds.

TheGF CSI Medical Service ETF closely tracks the CSI Medical Index. This index selects listed company securities in the medical and health industry with businesses involving medical devices, medical services, medical informatization and other medical themes as index samples, aiming to reflect the overall performance of medical theme listed company securities.

Data shows that as of December 31, 2025, the top 10 constituent stocks by weight of the CSI Medical Index (399989) were WuXi AppTec, Mindray Medical, United Imaging Healthcare, Aier Eye Hospital Group, Pharmaron Beijing, Tigermed, Yuyue Medical, Neusoft Medical, Aimeike (Amicco), and Huatai Medical. The total weight of these top 10 stocks accounted for 51.42%. (The stocks listed above are only index components and do not constitute specific investment recommendations.)

BOCOM International Securities stated that with the acceleration of population aging, the continuous improvement of residents' health awareness, and the gradual diversification of the payment system, private healthcare is playing an increasingly important role in supplementing the public medical system and meeting differentiated and high-quality medical needs. Leading enterprises with professional depth, brand advantages, and refined operation capabilities are expected to continuously increase their market share and release profit elasticity.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.